Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Receivables - Other (2021 - 2025)

Historic Receivables - Other for Universe Pharmaceuticals (UPC) over the last 5 years, with Q3 2025 value amounting to $2280.7 billion.

  • Universe Pharmaceuticals' Receivables - Other rose 4014779.6% to $2280.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2280.7 billion, marking a year-over-year increase of 4014779.6%. This contributed to the annual value of $2280.7 billion for FY2025, which is 4014779.6% up from last year.
  • According to the latest figures from Q3 2025, Universe Pharmaceuticals' Receivables - Other is $2280.7 billion, which was up 4014779.6% from $5.7 billion recorded in Q3 2024.
  • In the past 5 years, Universe Pharmaceuticals' Receivables - Other registered a high of $2280.7 billion during Q3 2025, and its lowest value of $236982.0 during Q3 2021.
  • For the 5-year period, Universe Pharmaceuticals' Receivables - Other averaged around $457.3 billion, with its median value being $391.6 million (2023).
  • Its Receivables - Other has fluctuated over the past 5 years, first skyrocketed by 134715.5% in 2024, then soared by 4014779.6% in 2025.
  • Universe Pharmaceuticals' Receivables - Other (Quarter) stood at $236982.0 in 2021, then surged by 50.34% to $356290.0 in 2022, then soared by 109801.48% to $391.6 million in 2023, then skyrocketed by 1347.16% to $5.7 billion in 2024, then skyrocketed by 40147.8% to $2280.7 billion in 2025.
  • Its Receivables - Other was $2280.7 billion in Q3 2025, compared to $5.7 billion in Q3 2024 and $391.6 million in Q3 2023.